InvestorsHub Logo
Followers 2
Posts 62
Boards Moderated 0
Alias Born 07/02/2013

Re: None

Wednesday, 08/05/2020 2:01:40 PM

Wednesday, August 05, 2020 2:01:40 PM

Post# of 16722


ALGERNON ANNOUNCES ENROLLMENT OF FIRST PATIENT IN 2B/3 HUMAN STUDY OF IFENPRODIL FOR TREATMENT OF COVID-19 || TRIAL WILL BEGIN AS A PHASE 2B STUDY OF AN AGGREGATE OF 150 PATIENTS